Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics

NCT02573168 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

GENETIC: GeneSight Psychotropic (GEN)
GENETIC: Enhanced-GeneSight Psychotropic (E-GEN)
OTHER: Treatment as Usual (TAU)

Sponsor

St. Joseph's Healthcare Hamilton

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]